Clinical, radiological, and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection

Awake prone positioning for COVID-19 acute respiratory failure: imaging and histological background

(2022) Sara Piciucchi et al.   Lancet Respiratory Medicine

“ILD” after COVID‐19 Infection: A Catalogue of Uncertainties

(2021) Athol U. Wells et al.   RADIOLOGY

Six-Month Follow-up Chest CT findings after Severe COVID-19 Pneumonia

(2021) Xiaoyu Han et al.   RADIOLOGY

Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort

(2021) Jade Ghosn et al.   CLINICAL MICROBIOLOGY AND INFECTION

Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls

(2021) David Montani et al.   EUROPEAN RESPIRATORY JOURNAL

The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime

(2021) Marco Chilosi et al.   MODERN PATHOLOGY

Post-acute COVID-19 syndrome

(2021) Ani Nalbandian et al.   NATURE MEDICINE

Systemic and organ-specific immune-related manifestations of COVID-19

(2021) Manuel Ramos-Casals et al.   Nature Reviews Rheumatology

Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies

(2021) Claudio Doglioni et al.   RESPIRATION

Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations

(2021) S. Oldani et al.   Pulmonology

Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting

(2021) Mayssam Nehme et al.   ANNALS OF INTERNAL MEDICINE

Pulmonary Parenchymal Changes in COVID-19 Survivors

(2021) Ashley Diaz et al.   ANNALS OF THORACIC SURGERY

Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients

(2021) Maddalena Peghin et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis

(2021) César Fernández-de-las-Peñas et al.   European Journal of Internal Medicine

Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study

(2021) Gilles Darcis et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?

(2021) Elisabetta A Renzoni et al.   LANCET

CT of Post-Acute Lung Complications of COVID-19

(2021) Joshua J. Solomon et al.   RADIOLOGY

Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity

(2021) Linh T. Bui et al.   Nature Communications

Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19

(2021) Tahmina Nasserie et al.   JAMA Network Open

Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19

(2021) Elda Righi et al.   Infectious Diseases and Therapy

Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection

(2021) Annoor Awadasseid et al.   BIOMEDICINE & PHARMACOTHERAPY

Indoleamine 2,3‐dioxygenase ( IDO )‐1 and IDO ‐2 activity and severe course of COVID ‐19

(2021) Lihui Guo et al.   JOURNAL OF PATHOLOGY

PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response

(2021) Cristian Loretelli et al.   JCI Insight

Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis

(2021) Laura Ansone et al.   Microbiology Spectrum

Immunology of COVID-19: current state of the science

(2020) Nicolas Vabret et al.   IMMUNITY

COVID‐19 related lung pathology: old patterns in new clothing?

(2020) Andrew G Nicholson et al.   HISTOPATHOLOGY

Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)

(2020) Silvia Vivarelli et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients

(2019) Claudia Ravaglia et al.   BMC Pulmonary Medicine

Contribution of IDO to human respiratory syncytial virus infection

(2019) Felipe M. Benavente et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Novel Role for PD-1:PD-L1 as Mediator of Pulmonary Vascular Endothelial Cell Functions in Pathogenesis of Indirect ARDS in Mice

(2018) Joanne Lomas-Neira et al.   Frontiers in Immunology

Respiratory syncytial virus infection accelerates lung fibrosis through the unfolded protein response in a bleomycin-induced pulmonary fibrosis animal model

(2017) Lina Wang et al.   Molecular Medicine Reports

Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin and β-tubulin-III in idiopathic pulmonary fibrosis

(2016) Marco Chilosi et al.   MODERN PATHOLOGY

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors

(2015) Michael Platten et al.   Frontiers in Immunology

PD-1 blockade induces responses by inhibiting adaptive immune resistance

(2014) Paul C. Tumeh et al.   NATURE

Transbronchial Lung Cryobiopsy in the Diagnosis of Fibrotic Interstitial Lung Diseases

(2014) Gian Luca Casoni et al.   PLoS One

Endothelial Indoleamine 2,3-Dioxygenase Protects against Development of Pulmonary Hypertension

(2013) Yongguang Xiao et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema

(2013) Marco Chilosi et al.   Translational Research

Mechanisms of Indirect Acute Lung Injury

(2011) Sean F. Monaghan et al.   ANNALS OF SURGERY